As CMS Chief, Brooks-LaSure Could Turn Quickly To Medicare Drug Spending Reforms
Executive Summary
Chiquita Brooks-LaSure would be in a key position to implement the Biden Administration’s drug pricing priorities and is familiar with the balancing act needed when considering competing interests among stakeholders as policies are shaped.
You may also be interested in...
Becerra Takes The Helm At HHS; More Visibility On Administration’s Drug Pricing Priorities To Follow
Becerra’s HHS has a new crop of former Capitol Hill staffers in its policy ranks who are well versed on legislation in the health care realm, including prescription drug pricing reform. That will help advance the Administration’s agenda.
Pharma Gets Warm Spotlight At White House Event Showcasing J&J-Merck Collaboration
Biden Administration seeks to put its stamp on a new phase of the US government’s collaboration with the pharma industry against COVID-19.
Pharma Gets Warm Spotlight At White House Event Showcasing J&J-Merck Collaboration
Biden Administration seeks to put its stamp on a new phase of the US government’s collaboration with the pharma industry against COVID-19.